Quality-control culture system restores diabetic endothelial progenitor cell vasculogenesis and accelerates wound closure

Diabetes

Volumn 62, Issue 9, 2013, Pages 3207-3217

  Tanaka, Rica ^a   Vaynrub, Max ^b   Masuda, Haruchika ^a   Ito, Rie ^a   Kobori, Michiru ^a   Miyasaka, Muneo ^c   Mizuno, Hiroshi ^a   Warren, Stephen M ^b   Asahara, Takayuki ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL COUNT; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; ENDOTHELIAL PROGENITOR CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUALITYCONTROL CULTURE SYSTEM; WOUND CLOSURE; ANIMAL; BIOLOGICAL THERAPY; BONE MARROW CELL; C57BL MOUSE; CAT; CELL DIFFERENTIATION; CYTOLOGY; ENDOTHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; MALE; METABOLISM; PHYSIOLOGY; STEM CELL; WOUND HEALING;

ANIMALS; BONE MARROW CELLS; CATS; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL CELLS; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; TISSUE THERAPY; WOUND HEALING;

EID: 84887338031     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1621     Document Type: Article

References (38)

1. Drake CJ. Embryonic and adult vasculogenesis. Birth Defects Res C Embryo Today 2003;69:73-82
2. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967
3. Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362-367
4. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med 2003;13:201-206
5. Tanaka R, Wada M, Kwon SM, et al. The effects of flap ischemia on normal and diabetic progenitor cell function. Plast Reconstr Surg 2008;121:1929-1942
6. Kwon SM, Lee YK, Yokoyama A, et al. Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization. J Mol Cell Cardiol 2011;51:308-317
7. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228
8. Tepper OM, Capla JM, Galiano RD, et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005;105:1068-1077
9. Ii M, Nishimura H, Iwakura A, et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 2005;111:1114-1120
10. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-864
11. Murayama T, Tepper OM, Silver M, et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 2002;30:967-972
12. Tepper OM, Carr J, Allen RJ Jr, et al. Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1alpha mediated bone marrow mobilization impair diabetic tissue repair. Diabetes 2010;59:1974-1983
13. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000;106:571-578
14. Loomans CJ, de Koning EJ, Staal FJ, et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004;53:195-199
15. Li Calzi S, Neu MB, Shaw LC, Grant MB. Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits. EPMA J 2010;1:88-100
16. Albiero M, Menegazzo L, Boscaro E, Agostini C, Avogaro A, Fadini GP. Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice. Dia-betologia 2011;54:945-953
17. Fadini GP, Sartore S, Albiero M, et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arte-rioscler Thromb Vasc Biol 2006;26:2140-2146
18. Neukomm LJ, Frei AP, Cabello J, et al. Loss of the RhoGAP SRGP-1 promotes the clearance of dead and injured cells in Caenorhabditis elegans. Nat Cell Biol 2011;13:79-86
19. Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001;103:634-637
20. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of is-chemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-436
21. Taguchi A, Soma T, Tanaka H, et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004;114:330-338
22. Lin CD, Allori AC, Macklin JE, et al. Topical lineage-negative progenitor-cell therapy for diabetic wounds. Plast Reconstr Surg 2008;122:1341-1351
23. Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J, Schatteman GC. CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res 2003;40:368-377
24. Tanaka R, Masuda H, Kato S, et al. Autologous G-CSF mobilized peripheral blood CD34(+) cell therapy for diabetic patients with chronic non-healing ulcer. Cell Transplant. 25 October 2012 [Epub ahead of print]
25. Jarajapu YP, Grant MB. The promise of cell-based therapies for diabetic complications: challenges and solutions. Circ Res 2010;106:854-869
26. Tan Q, Qiu L, Li G, et al. Transplantation of healthy but not diabetic outgrowth endothelial cells could rescue ischemic myocardium in diabetic rabbits. Scand J Clin Lab Invest 2010;70:313-321
27. Masuda H, Iwasaki H, Kawamoto A, et al. Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis. Stem Cells Transl Med 2012;1:160-171
28. Westermann D, Rutschow S, Van Linthout S, et al. Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus. Diabetologia 2006;49:2507-2513
29. Masuda H, Alev C, Akimaru H, et al. Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ Res 2011;109:20-37
30. Tanaka R, Wada M, Kwon S, et al. The effects of flap ischemia on normal and diabetic progenitor cell function. Plast Reconstr Surg 2008;121:1929-1942
31. Park S, Tepper OM, Galiano RD, et al. Selective recruitment of endothelial progenitor cells to ischemic tissues with increased neovascularization. Plast Reconstr Surg 2004;113:284-293
32. Pugazhenthi K, Kapoor M, Clarkson AN, Hall I, Appleton I. Melatonin accelerates the process of wound repair in full-thickness incisional wounds. J Pineal Res 2008;44:387-396
33. Carson FL. Histotechnology: A Self-Instructional Text. Chicago, ASCP Press, 1997
34. Fadini GP, Avogaro A. Potential manipulation of endothelial progenitor cells in diabetes and its complications. Diabetes Obes Metab 2010;12:570-583
35. Michaels J, Churgin SS, Blechman KM, Greives MR, Aarabi S, Galiano RD, Gurtner GC. db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Repair Regen 2007;15:665-670
36. Glotzbach JP, Levi B, Wong VW, Longaker MT, Gurtner GC. The basic science of vascular biology: implications for the practicing surgeon. Plast Reconstr Surg 2010;126:1528-1538
37. King SJ, Worth DC, Scales TM, Monypenny J, Jones GE, Parsons M. b1 integrins regulate fibroblast chemotaxis through control of N-WASP stability. EMBO J 2011;30:1705-1718
38. Bakker K, Apelqvist J, Schaper NC; International Working Group on Diabetic Foot Editorial Board. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 2012;28 (Suppl. 1):225-231